1. Home
  2. NNNN vs BBNX Comparison

NNNN vs BBNX Comparison

Compare NNNN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$24.20

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$13.94

Market Cap

613.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
BBNX
Founded
2021
2015
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
613.7M
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
NNNN
BBNX
Price
$24.20
$13.94
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$27.58
AVG Volume (30 Days)
88.1K
1.1M
Earning Date
04-28-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$6,920,153.00
$88,570,000.00
Revenue This Year
N/A
$53.88
Revenue Next Year
N/A
$34.86
P/E Ratio
$412.64
N/A
Revenue Growth
N/A
67.01
52 Week Low
$5.18
$8.89
52 Week High
$55.65
$32.71

Technical Indicators

Market Signals
Indicator
NNNN
BBNX
Relative Strength Index (RSI) 45.58 33.51
Support Level $21.09 $12.71
Resistance Level $28.00 $15.53
Average True Range (ATR) 6.58 1.02
MACD 0.16 0.44
Stochastic Oscillator 21.97 43.62

Price Performance

Historical Comparison
NNNN
BBNX

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: